Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingWages, Salaries and Other
Ratios

Sunshine Biopharma (SBFM) Depreciation & Amortization (IS): 2016-2024

Historic Depreciation & Amortization (IS) for Sunshine Biopharma (SBFM) over the last 4 years, with Mar 2024 value amounting to $42,618.

  • Sunshine Biopharma's Depreciation & Amortization (IS) rose 22.78% to $42,618 in Q1 2024 from the same period last year, while for Mar 2024 it was $83,911, marking a year-over-year increase of 87.69%. This contributed to the annual value of $223,527 for FY2024, which is 49.87% up from last year.
  • Sunshine Biopharma's Depreciation & Amortization (IS) amounted to $42,618 in Q1 2024, which was up 22.78% from $34,710 recorded in Q1 2023.
  • Sunshine Biopharma's 5-year Depreciation & Amortization (IS) high stood at $42,618 for Q1 2024, and its period low was $3,110 during Q1 2022.
  • Over the past 3 years, Sunshine Biopharma's median Depreciation & Amortization (IS) value was $34,710 (recorded in 2023), while the average stood at $26,813.
  • Data for Sunshine Biopharma's Depreciation & Amortization (IS) shows a peak YoY skyrocketed of 1,016.08% (in 2023) over the last 5 years.
  • Sunshine Biopharma's Depreciation & Amortization (IS) (Quarterly) stood at $3,110 in 2022, then surged by 1,016.08% to $34,710 in 2023, then climbed by 22.78% to $42,618 in 2024.
  • Its Depreciation & Amortization (IS) stands at $42,618 for Q1 2024, versus $34,710 for Q1 2023 and $3,110 for Q1 2022.